Oct 26 (Reuters) - iCo Therapeutics Inc ICO.V :
* Has engaged Corealis Pharma, for analytical development, formulation
optimization,scale-up of amphotericin B oral delivery system
* Preparation & regulatory filings for delivery system program to be completed
in 2016, with Phase 1A study data available in 2017
Source text for Eikon urn:newsml:reuters.com:*:nCNWVLrsJa
Further company coverage ICO.V